)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Masimo (MASI) investor relations material
Masimo Investor Day 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor Day 2025 summary3 Dec, 2025
Strategic focus and business transformation
Refocused on core healthcare and medical technology markets, divested non-core assets, and exited consumer business to drive growth and margin expansion.
Built a leadership team blending long-tenured and new talent, strengthened commercial leadership, unified sales and field teams, and expanded OEM partnerships, including a renewed multi-year agreement with Philips.
Emphasized execution, innovation, operational excellence, and high-value R&D in core areas, with three waves of innovation planned through 2028 and beyond.
Maintained high recurring revenue (80%), a large installed base (2.6M+ units), 98%+ renewal rates, and strong OEM relationships, creating high barriers to entry and market leadership.
Defended intellectual property, including a $634M patent win against Apple and ongoing litigation and ITC proceedings.
Growth algorithm and product innovation
Four growth pillars: accelerate U.S. pulse ox, increase international share, expand advanced monitoring, and execute new product launches, with double-digit growth targeted by 2028.
U.S. pulse ox market share targeted to rise from 55% toward 70-75% (or 58-60% by 2028), driven by new AI-enabled sensors and algorithms (OIRD, AFib) launching in 2026.
International pulse ox market (35% share) offers significant headroom, with tailored regional strategies and a Japan turnaround initiative.
Advanced monitoring (capnography, brain, hemodynamics) expected to drive 10%+ growth and 30% of overall growth, leveraging new commercial structures and AI-enabled products launching 2026-2028.
Ten new products, including next-gen Root platform, sensors, monitors, and wearables, to launch over three years from 2026, fueling post-2028 growth.
Financial guidance and performance targets
Long-range plan targets 7%-10% annual revenue growth (CAGR), ~30% operating margin, $8.00 adjusted EPS, and ~$1B cumulative operating cash flow by 2028.
FY2025 non-GAAP revenue guidance: $1,510M–$1,530M, with 8.2%–9.7% reported growth and EPS of $5.40–$5.55.
Margin expansion driven by 190 bps gross margin improvement, cost reductions, discontinued non-core products, and operating leverage.
$1 billion cumulative operating cash flow expected over next three years, with 70-80% cash flow conversion.
Capital allocation focused on reinvestment, share buybacks, debt paydown, and disciplined M&A in sensors, algorithms, and form factors.
Bridge the EPS gap to $8 by 2028
Impact of new AFib/OIRD algorithms on growth
Timeline for continuous monitoring as standard of care
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Masimo earnings date
Q4 202525 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Masimo Corporation is a medical technology company that develops noninvasive monitoring technologies and devices. The company’s product portfolio includes pulse oximetry, brain function monitoring, and hospital automation solutions. It serves hospitals, medical professionals, and consumers globally. Masimo Corporation is headquartered in Irvine, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage